{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T10:21:58Z","timestamp":1784542918546,"version":"3.55.0"},"reference-count":39,"publisher":"BMJ","issue":"3","license":[{"start":{"date-parts":[[2024,3,14]],"date-time":"2024-03-14T00:00:00Z","timestamp":1710374400000},"content-version":"unspecified","delay-in-days":13,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100012095","name":"Scottish Government","doi-asserted-by":"publisher","award":["DDTFRF15"],"award-info":[{"award-number":["DDTFRF15"]}],"id":[{"id":"10.13039\/100012095","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2024,2,9]]},"published-print":{"date-parts":[[2024,3]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To investigate the association between opioid replacement therapy (ORT) and benzodiazepine (BZD) coprescription and all-cause mortality compared with the prescription of ORT alone.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>Population-based cohort study.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Setting<\/jats:title>\n                    <jats:p>Scotland, UK.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Participants<\/jats:title>\n                    <jats:p>Participants were people prescribed ORT between January 2010 and end of December 2020 aged 18 years or above.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Main outcome measures<\/jats:title>\n                    <jats:p>All-cause mortality, drug-related deaths and non-drug related deaths.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Secondary outcome<\/jats:title>\n                    <jats:p>ORT continuous treatment duration.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Analysis<\/jats:title>\n                    <jats:p>Cox regression with time-varying covariates.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>During follow-up, 5776 of 46\u2009899 participants died: 1398 while on coprescription and 4378 while on ORT only. The mortality per 100 person years was 3.11 during coprescription and 2.34 on ORT only. The adjusted HR for all-cause mortality was 1.17 (1.10 to 1.24). The adjusted HR for drug-related death was 1.14 (95% CI, 1.04 to 1.24) and the hazard for death not classified as drug-related was 1.19 (95% CI, 1.09 to 1.30).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Coprescription of BZDs in ORT was associated with an increased risk of all-cause mortality, although with a small effect size than the international literature. Coprescribing was also associated with longer retention in treatment. Risk from BZD coprescription needs to be balanced against the risk from illicit BZDs and unplanned treatment discontinuation. A randomised controlled trial is urgently needed to provide a clear clinical direction.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration number<\/jats:title>\n                    <jats:p>\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"clintrialgov\" xlink:href=\"NCT04622995\">NCT04622995<\/jats:ext-link>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2023-074668","type":"journal-article","created":{"date-parts":[[2024,3,14]],"date-time":"2024-03-14T23:00:24Z","timestamp":1710457224000},"page":"e074668","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":11,"title":["Association between benzodiazepine coprescription and mortality in people on opioid replacement therapy: a population-based cohort study"],"prefix":"10.1136","volume":"14","clinical-trial-number":[{"clinical-trial-number":"nct04622995","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3652-2498","authenticated-orcid":false,"given":"Catherine Susan","family":"Best","sequence":"first","affiliation":[{"name":"Faculty of Health Sciences and Sport, University of Stirling, Stirling, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catriona","family":"Matheson","sequence":"additional","affiliation":[{"name":"University of Stirling, Stirling, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Robertson","sequence":"additional","affiliation":[{"name":"Muirhouse Medical Group, Edinburgh, UK"},{"name":"University of Edinburgh, Usher Institute, Edinburgh, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5409-700X","authenticated-orcid":false,"given":"Trina","family":"Ritchie","sequence":"additional","affiliation":[{"name":"NHS Greater Glasgow and Clyde, Glasgow, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiona","family":"Cowden","sequence":"additional","affiliation":[{"name":"NHS Tayside, Dundee, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josh","family":"Dumbrell","sequence":"additional","affiliation":[{"name":"University of Stirling, Stirling, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clare","family":"Duncan","sequence":"additional","affiliation":[{"name":"NHS Ayrshire and Arran, Ayr, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karthigayan","family":"Kessavalou","sequence":"additional","affiliation":[{"name":"NHS Ayrshire and Arran, Ayr, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Woolston","sequence":"additional","affiliation":[{"name":"NHS Ayrshire and Arran, Ayr, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1307-2375","authenticated-orcid":false,"given":"Joe","family":"Schofield","sequence":"additional","affiliation":[{"name":"School of Health in Social Science, The University of Edinburgh College of Humanities and Social Science, Edinburgh, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2024,3,14]]},"reference":[{"key":"2025120520345202000_14.3.e074668.1","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.20622","article-title":"Comparative effectiveness of different treatment pathways for opioid use disorder","volume":"3","author":"Wakeman","year":"2020","journal-title":"JAMA Netw Open"},{"key":"2025120520345202000_14.3.e074668.2","doi-asserted-by":"crossref","unstructured":"The Lancet . Managing the opioid crisis in North America and beyond. Lancet 2022;399. doi:10.1016\/S0140-6736(22)00200-8","DOI":"10.1016\/S0140-6736(22)00200-8"},{"key":"2025120520345202000_14.3.e074668.3","unstructured":"National Records of Scotland . Vital events Edinburgh: national records of Scotland. 2023. Available: https:\/\/www.nrscotland.gov.uk\/statistics-and-data\/statistics\/statistics-by-theme\/vital-events"},{"key":"2025120520345202000_14.3.e074668.4","unstructured":"Office for National Statistics (ONS) . Statistical Bulletin, deaths related to drug poisoning in England and Wales: 2022 registrations. 2023. Available: https:\/\/www.ons.gov.uk\/peoplepopulationandcommunity\/birthsdeathsandmarriages\/deaths\/bulletins\/deathsrelatedtodrugpoisoninginenglandandwales\/2022registrations"},{"key":"2025120520345202000_14.3.e074668.5","doi-asserted-by":"crossref","first-page":"103512","DOI":"10.1016\/j.drugpo.2021.103512","article-title":"From the clinic to the street: the changing role of benzodiazepines in the Scottish overdose epidemic","volume":"100","author":"McAuley","year":"2022","journal-title":"Int J Drug Policy"},{"key":"2025120520345202000_14.3.e074668.6","unstructured":"Johnson C , Barnsdale L , McAuley A . Investigating the role of benzodiazepines in drug-related mortality: a systematic review undertaken on behalf of the Scottish national forum on drug-related deaths; 2016."},{"key":"2025120520345202000_14.3.e074668.7","unstructured":"EMCDDA . The misuse of benzodiazepines among high-risk opioid users in Europe. Portugal: EMCDDA, 2018."},{"key":"2025120520345202000_14.3.e074668.8","unstructured":"Information Services Division . Scottish drug misuse database: overview of initial assessments for specialist drug treatment 2018\/19. Edinburgh NHS Scotland; 2020."},{"key":"2025120520345202000_14.3.e074668.9","doi-asserted-by":"crossref","DOI":"10.1186\/1471-244X-11-90","article-title":"Benzodiazepine use and misuse among patients in a methadone program","volume":"11","author":"Chen","year":"2011","journal-title":"BMC Psychiatry"},{"key":"2025120520345202000_14.3.e074668.10","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2019.02.033"},{"key":"2025120520345202000_14.3.e074668.11","unstructured":"Clinical Guidelines on Drug Misuse and Dependence Independent Expert Working Group . Drug misuse and dependence: UK guidelines on clinical management. London: Department of Health, 2017."},{"key":"2025120520345202000_14.3.e074668.12","unstructured":"Public Health Scotland . MAT standards informed response for benzodiazepine harm reduction. 2021. Available: https:\/\/drugdeathstaskforce.scot\/media\/1229\/mat-standards-informed-response-for-benozdiazepine-harm-reduction_interim-guidance_june21.pdf"},{"key":"2025120520345202000_14.3.e074668.13","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.drugalcdep.2017.01.013","article-title":"Benzodiazepine, Z-drug and pregabalin prescriptions and mortality among patients in opioid maintenance treatment-A nation-wide register-based open cohort study","volume":"174","author":"Abrahamsson","year":"2017","journal-title":"Drug Alcohol Depend"},{"key":"2025120520345202000_14.3.e074668.14","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002965","article-title":"Prescription of benzodiazepines, Z-drugs, and Gabapentinoids and mortality risk in people receiving opioid agonist treatment: observational study based on the UK clinical practice research datalink and office for National Statistics death records","volume":"16","author":"Macleod","year":"2019","journal-title":"PLoS Med"},{"key":"2025120520345202000_14.3.e074668.15","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-038692","article-title":"Concurrent use of opioids and benzodiazepines\/Z-drugs in Alberta, Canada and the risk of hospitalisation and death: a case cross-over study","volume":"10","author":"Sharma","year":"2020","journal-title":"BMJ Open"},{"key":"2025120520345202000_14.3.e074668.16","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1177\/0269881116675508","article-title":"Benzodiazepine maintenance in opiate substitution treatment: good or bad? A retrospective primary care case-NOTE review","volume":"31","author":"Bakker","year":"2017","journal-title":"J Psychopharmacol"},{"key":"2025120520345202000_14.3.e074668.17","doi-asserted-by":"publisher","DOI":"10.1111\/add.14886"},{"key":"2025120520345202000_14.3.e074668.18","doi-asserted-by":"crossref","first-page":"108466","DOI":"10.1016\/j.drugalcdep.2020.108466","article-title":"Factors associated with early and later dropout from methadone maintenance treatment in specialist addiction clinics: a six-year cohort study using proportional hazards frailty models for recurrent treatment episodes","volume":"219","author":"Durand","year":"2021","journal-title":"Drug Alcohol Depend"},{"key":"2025120520345202000_14.3.e074668.19","first-page":"55","article-title":"Outcomes of clonazepam maintained benzodiazepine-heroin addicted patients during methadone maintenance: a descriptive case series","volume":"16","author":"Maremmani","year":"2014","journal-title":"Heroin Addict Relat Clin Probl"},{"key":"2025120520345202000_14.3.e074668.20","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1097\/ADM.0000000000000476","article-title":"Evaluating the impact of prescribed versus nonprescribed benzodiazepine use in methadone maintenance therapy: results from a population-based retrospective cohort study","volume":"13","author":"Eibl","year":"2019","journal-title":"J Addict Med"},{"key":"2025120520345202000_14.3.e074668.21","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2013.04.006"},{"key":"2025120520345202000_14.3.e074668.22","unstructured":"National Institute for Health and Care Excellence . Substance dependence: National Institute for health and care excellence. 2023. Available: https:\/\/bnf.nice.org.uk\/treatment-summaries\/substance-dependence"},{"key":"2025120520345202000_14.3.e074668.23","unstructured":"NHS Scotland . Prescribing information system. Edinburgh NHS Scotland; 2022. Available: https:\/\/www.ndc.scot.nhs.uk\/National-Datasets\/data.asp?SubID=9"},{"key":"2025120520345202000_14.3.e074668.24","unstructured":"NHS Scotland . CHI number. Edinburgh NHS National Services Scotland; 2021. Available: https:\/\/www.ndc.scot.nhs.uk\/Dictionary-A-Z\/Definitions\/index.asp?Search=C&ID=128&Title=CHI%20Number"},{"key":"2025120520345202000_14.3.e074668.25","unstructured":"NHS Scotland . Use of the national safe haven. Edinburgh NHS Scotland; 2023. Available: https:\/\/www.isdscotland.org\/products-and-services\/edris\/use-of-the-national-safe-haven"},{"key":"2025120520345202000_14.3.e074668.26","unstructured":"Scottish Government . Scottish index of multiple deprivation 2020. 2020. Available: https:\/\/www.gov.scot\/collections\/scottish-index-of-multiple-deprivation-2020 [Accessed 17 Nov 2023]."},{"key":"2025120520345202000_14.3.e074668.27","unstructured":"Scottish Government . Overview - Scottish government urban rural classification. 2016. Available: www.gov.scot [Accessed 17 Nov 2023]."},{"key":"2025120520345202000_14.3.e074668.28","unstructured":"StataCorp . Stata statistical software, 17 ed. College Station, TX, USA StataCorp LLC; 2021."},{"key":"2025120520345202000_14.3.e074668.29","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1007\/s11606-019-05545-y","article-title":"Risk of overdose with exposure to prescription opioids, benzodiazepines, and nonbenzodiazepine sedative-hypnotics in adults: a retrospective cohort study","volume":"35","author":"Cho","year":"2020","journal-title":"J Gen Intern Med"},{"key":"2025120520345202000_14.3.e074668.30","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.h2698","article-title":"Benzodiazepine prescribing patterns and deaths from drug overdose among US veterans receiving opioid analgesics: case-cohort study","volume":"350","author":"Park","year":"2015","journal-title":"BMJ"},{"key":"2025120520345202000_14.3.e074668.31","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/pme.12907","article-title":"Cohort study of the impact of high-dose opioid analgesics on overdose mortality","volume":"17","author":"Dasgupta","year":"2016","journal-title":"Pain Med"},{"key":"2025120520345202000_14.3.e074668.32","doi-asserted-by":"publisher","DOI":"10.4103\/0976-3147.91934"},{"key":"2025120520345202000_14.3.e074668.33","doi-asserted-by":"publisher","DOI":"10.1080\/09595239800187561"},{"key":"2025120520345202000_14.3.e074668.34","doi-asserted-by":"crossref","first-page":"108781","DOI":"10.1016\/j.jsat.2022.108781","article-title":"Long-acting depot buprenorphine in people who are homeless: views and experiences","volume":"139","author":"Matheson","year":"2022","journal-title":"J Subst Abuse Treat"},{"key":"2025120520345202000_14.3.e074668.35","doi-asserted-by":"publisher","DOI":"10.1111\/j.1533-2500.2010.00378.x"},{"key":"2025120520345202000_14.3.e074668.36","unstructured":"Matheson C , Best C , Cowden F . BENZORT final report. University of Stirling;"},{"key":"2025120520345202000_14.3.e074668.37","unstructured":"Scottish Drugs Forum . Older people with drug problems in Scotland: addressing the needs of an ageing population. Glasgow Scottish Drugs Forum; 2017."},{"key":"2025120520345202000_14.3.e074668.38","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1080\/10550880802122620","article-title":"The impact of benzodiazepine use on methadone maintenance treatment outcomes","volume":"27","author":"Brands","year":"2008","journal-title":"J Addict Dis"},{"key":"2025120520345202000_14.3.e074668.39","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1001\/jamapsychiatry.2019.4170","article-title":"All-cause and cause-specific mortality among people using extramedical opioids: a systematic review and meta-analysis","volume":"77","author":"Larney","year":"2020","journal-title":"JAMA Psychiatry"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2023-074668","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T04:35:04Z","timestamp":1764995704000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2023-074668"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":39,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2024,3,14]]},"published-print":{"date-parts":[[2024,3]]}},"alternative-id":["10.1136\/bmjopen-2023-074668"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2023-074668","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3]]}}}